Syneos Health, Inc.
Syneos Health, Inc. Fundamental Analysis
Syneos Health, Inc. (SYNH) shows weak financial fundamentals with a PE ratio of 16.61, profit margin of 4.94%, and ROE of 7.72%. The company generates $5.4B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 42.0/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze SYNH's fundamental strength across five key dimensions:
Efficiency Score
WeakSYNH struggles to generate sufficient returns from assets.
Valuation Score
ExcellentSYNH trades at attractive valuation levels.
Growth Score
ModerateSYNH shows steady but slowing expansion.
Financial Health Score
ExcellentSYNH maintains a strong and stable balance sheet.
Profitability Score
WeakSYNH struggles to sustain strong margins.
Key Financial Metrics
Is SYNH Expensive or Cheap?
P/E Ratio
SYNH trades at 16.61 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, SYNH's PEG of 0.17 indicates potential undervaluation.
Price to Book
The market values Syneos Health, Inc. at 1.27 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 2.39 times EBITDA. This is generally considered low.
How Well Does SYNH Make Money?
Net Profit Margin
For every $100 in sales, Syneos Health, Inc. keeps $4.94 as profit after all expenses.
Operating Margin
Core operations generate 7.48 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $7.72 in profit for every $100 of shareholder equity.
ROA
Syneos Health, Inc. generates $3.25 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Syneos Health, Inc. generates limited operating cash flow of $430.07M, signaling weaker underlying cash strength.
Free Cash Flow
Syneos Health, Inc. produces free cash flow of $335.93M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $3.24 in free cash annually.
FCF Yield
SYNH converts 7.48% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
16.61
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.17
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.27
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.83
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.83
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.13
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.08
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How SYNH Stacks Against Its Sector Peers
| Metric | SYNH Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 16.61 | 29.43 | Better (Cheaper) |
| ROE | 7.72% | 800.00% | Weak |
| Net Margin | 4.94% | -20145.00% (disorted) | Weak |
| Debt/Equity | 0.83 | 0.30 | Weak (High Leverage) |
| Current Ratio | 1.13 | 4.64 | Neutral |
| ROA | 3.25% | -17936.00% (disorted) | Weak |
SYNH outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Syneos Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation